YEAH: With this new instalment of war and piece, if I have skimmed it correctly, the theory is that the FDA deliberately approved a blatantly failed amyloid theory drug to create the awareness required to once and for all kill that decades old dogma - and especially to make way for blarcamesine.
A valiant, heroic and selfless action of FDA executives potentially sacrificing their reputations and careers in the service of humanity and tax payer's money.
Bio is a heavyweight on this board, writes with a gift. I value his contributions highly, even when he takes a summer day off to write brilliant fiction.
IF the FDA really wanted to discredit the amyloid thesis, it would have turned DOWN biogen after much show and said don't worry there are alternative treatments on the horizon.
Anyone who follows CYDY and leronlimab knows this FDA is unusually corrupt even by swamp standards. Janet Woodcock & crew deserve the "John the Baptist" treatment at the next FDA dinner.
CYDY is only now figuring out what Dr. M knew all along: A small biotech will have to go around the FDA, not through it.
News 
Market Data 
Discover 
AI
